How Will the FDA Protect Whistleblowers?

DATE: March 5, 2014 | Andre Francisco

Topics: Whistleblower Protections | Related Content: Food and Drug Administration

Angela Canterbury, the Director of Public Policy at POGO, challenges the Food and Drug Administration's policy for protecting whistleblowers and their legal disclosures. From a hearing of the House Oversight and Government Reform Committee.

For more information, see Canterbury's full written testimony and our blog post about the hearing.

comments powered by Disqus

Related Work